Eli Lilly: First Healthcare Giant to $1T Market Cap

Eli Lilly, a pharmaceutical pioneer since 1876, recently reached a monumental milestone by briefly becoming the first healthcare company to surpass a one trillion dollar market capitalization. This achievement is largely attributed to their groundbreaking advancements in the GLP-one drug space, with their weight loss injection, Zepbound, and diabetes treatment, Mounjaro, leading the charge. Mounjaro, which mimics two gut hormones to reduce appetite and improve sugar and fat processing, has already surpassed one billion dollars in sales in its first full year. With the weight loss drug market projected to reach one hundred fifty billion dollars by the early two thousand thirties, Eli Lilly is well-positioned to maintain its dominant status.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.